Therapy News and Research

RSS

Seroquel (quetiapine), may be an effective treatment option for patients with schizophrenia

A new study, published in the journal Human Psychopharmacology: Clinical and Experimental, shows that the atypical antipsychotic Seroquel (quetiapine), may be an effective treatment option for patients with schizophrenia who exhibit aggressive behaviour during psychotic episodes.

19 Jun 2005

New antibiotic approved by FDA will fight bacterial infections in hospitals

The U.S. Food and Drug Administration (FDA) has given it's approval for a new antibiotic to fight bacterial infections.

19 Jun 2005

Most common form of lung cancer may begin in a group of newly isolated lung stem cells

Working in a mouse model, the researchers isolated a novel type of lung cell that can divide into fresh copies of itself and into the two more specialized kinds of cells deep in the lung.

16 Jun 2005

Findings may help scientists improve the existing vaccine for yellow fever

In one of the first molecular studies of the human antibody response to yellow fever, Howard Hughes Medical Institute (HHMI) researchers and their colleagues have found the crucial bit of virus that people's immune systems need to spot and quash this often-fatal re-emerging disease.

16 Jun 2005

Fine tuning drug levels in neuroblastoma patients is effective

Monitoring and fine tuning the levels of the cancer drug topotecan in children with neuroblastoma holds promise for maximizing the drug's effectiveness while reducing its toxicity, according to investigators at St. Jude Children's Research Hospital.

16 Jun 2005

Columbia University launches multi-year campaign to support stem cell researc

Columbia University Medical Center (CUMC) has announced that it is halfway toward realizing the first phase of a multi-year campaign to build upon the university’s groundbreaking stem cell research and lead the effort to fully realize the therapeutic potential of stem cells.

16 Jun 2005

Chromium picolinate significantly reduces weight gain associated with common antidiabetic medication

...according to a study released today. Researchers at the Pennington Biomedical Research Center (PBRC), who conducted the study, also found that chromium significantly improved blood sugar control and insulin sensitivity.

16 Jun 2005

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.

16 Jun 2005

Immunomedics awarded U.S. and Australian patents

Immunomedics announced that it has received notices that the U.S. and Australian patent offices have allowed claims in respective patent applications covering methods for treating a wide range of autoimmune diseases using monoclonal antibodies that bind to the CD22 antigen present on B-lymphocytes.

16 Jun 2005

Schiavo finally laid to rest

Hopefully autopsy findings released today will finally allow Terri Schiavo to be laid to rest.

16 Jun 2005

Doctor blames parents for return of sick girl's cancer

Thirteen year old Katie Wernecke is back in hospital after doctors confirmed the girls Hodgkin's disease had returned.

16 Jun 2005

Obese teens shed weight with combo diet, exercise, therapy and drug program

New research suggests that when combined with a low-calorie diet, exercise and behavioral therapy, treatment with the drug Xenical significantly improves weight management for obese teenagers.

16 Jun 2005

Pioneering new technology helps ease dementia

In a remarkable enterprise psychologists at St Andrews University, computer experts at Dundee University, and researchers at the Duncan of Jordanstone College of Art in Dundee, have collaborated to produce a "memory jukebox".

16 Jun 2005

Protocol used to treat the first known survivor of rabies without prior vaccination published

The protocol used to treat the first known survivor of rabies without prior vaccination is published in the June 16, 2005, issue of the New England Journal of Medicine. It is hoped that this approach can be replicated, tested, and provide a guide for treating this fatal condition, especially in parts of the world where the incidence of rabies is rampant.

15 Jun 2005

Diabetes patients may benefit most from minor surgery plus antibiotics

A small sore on a toe may not seem like a major medical threat. But for the millions of people who have diabetes and other conditions, it can be the first step on a road that leads to the amputation of a foot -- or even a leg.

15 Jun 2005

FDA approves Xeloda (capecitabine) oral chemotherapy

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xeloda (capecitabine) -- an innovative oral chemotherapy -- for the adjuvant (post-surgery) treatment of patients with Dukes' C colon cancer.

15 Jun 2005

Oral liquid Hydroxyurea promising for long-term use in babies with sickle cell disease

15 Jun 2005

Promising new tuberculosis drug enters clinical trial

A promising new drug candidate that may be effective against both actively dividing and slow-growing Mycobacterium tuberculosis (M. tb) has begun testing in humans, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced this week.

15 Jun 2005

Report on Hispanics and genes, culture, and medicines highlights the rise of individualized medicine

"The FDA's review today of BiDil could make it the first drug approved specifically for African Americans and marks the end of 'one-size-fits-all' medicine," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health (the Alliance), the nation's leading Hispanic health advocacy group.

15 Jun 2005

Acute coronary syndrome patients at increased risk of stroke

Patients hospitalized with chest pain or heart attack symptoms are at an increased risk of stroke even after being discharged, according to a study published in Circulation: Journal of the American Heart Association.

15 Jun 2005

Therapy News and Research

Seroquel (quetiapine), may be an effective treatment option for patients with schizophrenia

New antibiotic approved by FDA will fight bacterial infections in hospitals

Most common form of lung cancer may begin in a group of newly isolated lung stem cells

Findings may help scientists improve the existing vaccine for yellow fever

Fine tuning drug levels in neuroblastoma patients is effective

Columbia University launches multi-year campaign to support stem cell researc

Chromium picolinate significantly reduces weight gain associated with common antidiabetic medication

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Immunomedics awarded U.S. and Australian patents

Schiavo finally laid to rest

Doctor blames parents for return of sick girl's cancer

Obese teens shed weight with combo diet, exercise, therapy and drug program

Pioneering new technology helps ease dementia

Protocol used to treat the first known survivor of rabies without prior vaccination published

Diabetes patients may benefit most from minor surgery plus antibiotics

FDA approves Xeloda (capecitabine) oral chemotherapy

Oral liquid Hydroxyurea promising for long-term use in babies with sickle cell disease

Promising new tuberculosis drug enters clinical trial

Report on Hispanics and genes, culture, and medicines highlights the rise of individualized medicine

Acute coronary syndrome patients at increased risk of stroke

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News